Long-term Change in Cholesterol in Relation to Inflammation-sensitive Plasma Proteins: a Longitudinal Study.
From: Department of Clinical Science, Section for Epidemiology, Lund University, Malmö University Hospital, Sweden. gunnar.engstrom@med.lu.se
Annals of epidemiology
- Publish Date: Jan 2007
- ISSN: 1047-2797
- Volume: 17
- Issue: 1
- Pages: 57-63
- Medium: Print
- Language: English
- Citation (JAMA): Engström Gunnar, Hedblad Bo, Janzon Lars, et al. Long-term Change in Cholesterol in Relation to Inflammation-sensitive Plasma Proteins: a Longitudinal Study.. Jan 2007;17:57-63
Abstract
PURPOSE: The nature of the relationship between inflammation and elevated serum lipid levels is incompletely understood. This longitudinal study explores whether elevated levels of inflammation-sensitive plasma proteins (ISPs) are a risk factor for developing increased cholesterol and triglyceride levels. METHODS: Five ISPs (fibrinogen, orosomucoid, alpha1-antitrypsin, haptoglobin, and ceruloplasmin) were measured in a population-based cohort of nondiabetic healthy men aged 38 to 50 years at baseline. Subjects were reexamined after a mean of 6.2 years. The development of hypercholesterolemia (cholesterol>or=6.5 mmol/L [>or=251 mg/dL]) and hypertriglyceridemia (triglycerides>or=2.3 mmol/L [>or=204 mg/dL]) during follow-up was studied in relation to the number of elevated levels of ISPs (i.e., in the top quartile). RESULTS: Of men with initially normal cholesterol levels (<6.5 mmol/L; n=2224), proportions of men with no, one, two, and three or more elevated ISP levels at baseline who developed hypercholesterolemia were 12%, 13%, 16%, and 20%, respectively (p for trend=0.0002). This relationship remained significant after adjustments for cholesterol level at baseline and other confounding factors. The relationship between ISP levels and future hypertriglyceridemia was attenuated and nonsignificant after adjustments for confounding factors. CONCLUSION: In apparently healthy men with initially normal cholesterol levels, elevated ISP levels are a risk factor for development of hypercholesterolemia.
Mesh Headings (Keywords): Acute-Phase Proteins, Adult, Biological Markers, Cardiovascular Diseases, Ceruloplasmin, Cholesterol, Fibrinogen, Haptoglobins, Humans, Hypercholesterolemia, Hypertriglyceridemia, Inflammation, Longitudinal Studies, Male, Mass Screening, Middle Aged, Orosomucoid, Risk Factors, Triglycerides, alpha 1-Antitrypsin
Check for Full Text / PubMed Unique Identifier (PMID): 17178329
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.